Epiminder
Andrew Niemiec has years of experience in the field, working in various capacities such as a Senior Product Engineer at Epiminder, managing AI R&D projects at Signostics Pty Ltd, and completing a summer internship as a Biomedical Engineer at Austin Hospital. Andrew's educational background includes obtaining a Bachelor of Science in Physiology and a Bachelor of Engineering in Electrical and Electronics Engineering from Monash University.
Epiminder
Epiminder is a medical device company developing the next generation brain monitoring technology. The company’s first product, the Minder™ system, is an implantable EEG monitoring system designed to detect epileptic seizures. Through long term and continuous EEG measurements, the system will provide unparalleled insights into brain activity, significantly improving the diagnosis and management of epilepsy and helping people with epilepsy take back control of their lives. Epilepsy is complex neurological condition which affects over 80 million people worldwide, 30% of whom don’t respond to medication. The Minder™ system consists of a small implant placed just under the scalp, a multi-channel electrode lead running across the skull for full brain coverage and AI-based automatic seizure detection software. It is currently in clinical trial. Epiminder is a privately held company and is based in Melbourne, Australia with an office in Dallas, TX USA.